medline.ch Respirationstrakt Neoplasie

	Cost-effectiveness of pirfenidone for patients with cancer and grade 2 or grade 3 radiation-induced lung injury: A modeling study. PLoS Med Pan QY, Wang YX, Tang XY, Hou Z, Dong BQ, Li QW, Chen BQ, Bai SM, Wu CF, Chen M. PMID: 42555672 [PubMed - indexed for MEDLINE]
	Comparison Between EGFR-TKI Efficacy in Early-Stage Non-small Cell Lung Cancer and Advanced Non-small Cell Lung Cancer: A Systematic Review and Meta-analysis. Lung Wang B, Yao Y, Chen Z, Wu R, Sun J, Li X, Xu X, Si Y, Liu H. PMID: 42554774 [PubMed - indexed for MEDLINE]
	Pooled safety profiles of bispecific antibodies targeting PD-1/CTLA-4 or PD-1/VEGF in non-small cell lung cancer: a systematic review and single-arm meta-analysis. J Egypt Natl Canc Inst Ma J, Zhao W. PMID: 42554769 [PubMed - indexed for MEDLINE]
	Comments on 'Survival by Detection Pathway in Patients With Lung Cancer: A Nationwide Descriptive Epidemiological Study in Japan'. Int J Cancer Matsuzaka M, Tanaka R. PMID: 42554108 [PubMed - as supplied by publisher]
	Phantom-based evaluation of radiomics feature stability for low-dose CT lung cancer screening. Front Endocrinol (Lausanne) Zheng S, Yang X, Wang H, Gao Z, Ye P, Wang W, Li W, Meng D, Zhang S, Zhang W, Liu H, Huang S, Zhang C, Wang J, Hao J, Cui X. PMID: 42553098 [PubMed - indexed for MEDLINE]
	Safety and efficacy of drug-eluting beads versus conventional bronchial arterial chemoembolization for lung cancer: a systematic review and meta-analysis. Front Oncol Gong Z, Liu Y, Song Y, Li X, Tian Y, Li J, Qi C. PMID: 42553077 [PubMed]
	Aumolertinib Versus Osimertinib as First-Line Treatment for EGFR-Mutant Non-Small Cell Lung Cancer: AÂ Retrospective Real-World Multicenter Study. Int J Cancer Wang J, Qi P, Li J, Wang N, Fu C, Liu L, Li S, Li X, Hou X, Qiao H. PMID: 42552814 [PubMed - as supplied by publisher]
	Reply to: Comments on "Survival by Detection Pathway in Patients With Lung Cancer-A Nationwide Descriptive Epidemiological Study in Japan". Int J Cancer Koto R, Yamamoto A, Takashima I, Iwao C, Shin JH, Hayashi Y, Kitagawa H, Horie Y. PMID: 42552771 [PubMed - as supplied by publisher]
	Correction to 'A Prospective Observational Study of Anamorelin During Chemoimmunotherapy in Non-Small Cell Lung Cancer With Cachexia (SPIRAL-ANA)'. J Cachexia Sarcopenia Muscle PMID: 42552565 [PubMed - in process]
	Lung Cancer Patient Advocacy Progress and New Challenges Since 2006. J Thorac Oncol Pujol JL, Roy UB, Feldman J, Egwuenu C. PMID: 42552032 [PubMed - indexed for MEDLINE]
	Health Insurance Type and Lung Cancer Stage Shift Following Coverage of Screening. Health Serv Res Lian M, McBride T, Kozower B, Baggstrom M, Liu Y. PMID: 42551444 [PubMed - indexed for MEDLINE]
	Single-cell study reveals early alterations in peripheral blood immune responses at day 7 following microwave ablation for lung cancer. Cell Immunol Wu Y, Wei X, Yang W, Wang F, Wang J, Huang Z, Zou F, Liu J. PMID: 42551135 [PubMed - as supplied by publisher]
	Association between preoperative chronic steroid use and pulmonary embolism in adult tumor craniotomy: Linking role of platelet-to-white blood cell ratio. PLoS One Gong B, Liu S, Chen S, Yu L, Liu L, Tan L. PMID: 42550807 [PubMed - indexed for MEDLINE]
	The prognostic value of cachexia index in patients with lung cancer treated with immune checkpoint inhibitors: a propensity score matching analysis. Front Nutr Li H, Tian M, Wang W, Han Q, Jin X, Xu X. PMID: 42549216 [PubMed]
	Correction: First-line serplulimab plus chemotherapy versus chemotherapy alone in small-cell lung cancer patients with brain metastases: a multicenter, prospective cohort study. Front Immunol Zhang W, Yang X, Chen H, Pu X, Tuohetashi R, Wu X, Xie Z, Wu D, Cai Y, Jin S, Guo X, Yao K, Chen Y, Jiang G. PMID: 42549123 [PubMed - in process]
	Use and impact of risk-based eligibility models in low-dose computed tomography lung cancer screening: a systematic review. Public Health Rev Mikl VE, Azizzadeh M, Breyer MK, Ten Haaf K, Ritschl V, Simon J, Stamm T. PMID: 42549076 [PubMed]
	Foundation model-enhanced multimodal radiomics for predicting response to chemo-immunotherapy in advanced lung squamous cell carcinoma. Front Oncol Wang Z, Zhang Y, He C, Wang M, Cai J. PMID: 42548856 [PubMed]
	Tumor-associated neutrophils in lung adenocarcinoma: from mechanisms to therapeutic targeting. Front Immunol Zhang R. PMID: 42548795 [PubMed - indexed for MEDLINE]
	Innate Immune Cells in Non-Small Cell Lung Cancer: Roles in Tumor Progression and Therapeutic Responses. Cancer Innov Liu J, Jia J, Wang C, Zhou Z, Cheng Z, Zhang Z, Jiang X, Huang Z, Li C. PMID: 42548768 [PubMed]
	The composition alteration of gut microbiota in lung cancer: a systematic review and meta-analysis. Front Microbiol Xu X, Yu T, Wu H, Guo Y, Li M, Han Y, Zhao L, Yu X. PMID: 42548731 [PubMed]

Artikel 1 - 20 / 162054

Seite 1 von 8103



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung